Sfoglia per Autore
Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?
1997-01-01 Mini, E.; Nobili, S.; Periti, P.
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance?
2000-01-01 Mini, E.; Nobili, S.; Periti, P.
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery
2001-01-01 Mini, E.; Grassi, F.; Cherubino, P.; Nobili, S.; Periti, P.
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma
2001-01-01 Martoni, A.; Mini, E.; Pinto, C.; Nobili, S.; Gentile, A. L.; Dentico, P.; Angelelli, B.; Scicolone, S.; Piana, E.; Mazzei, T.
Oxaliplatinum and 5-fluorouracil in protracted infusion in the treatment of advanced colorectal cancer
2002-01-01 Gentile, A. L.; Pinto, C.; Mini, E.; Angelelli, B.; Nobili, S.; Piana, E.; Mazzei, T.; Martoni, A.
Oxaliplatin plus Raltitrexed in the treatment of patients with advanced colorectal cancer: A phase II study
2003-01-01 Martoni, A.; Mini, E.; Pinto, C.; Gentile, A. L.; Nobili, S.; Dentico, P.; Marino, A.; Scicolone, S.; Angelelli, B.; Mazzei, T.
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: A pilot study
2004-01-01 Mazzanti, R.; Giallombardo, A. L.; Mini, E.; Nobili, S.; Neri, B.; Arena, U.; Pantaleo, P.; Fabbroni, V.; Ghilardi, M.; Gattai, R.; Bandettini, L.
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers
2005-01-01 Morganti, M.; Ciantelli, M.; Giglioni, B.; Putignano, A. L.; Nobili, S.; Papi, L.; Landini, I.; Napoli, C.; Valanzano, R.; Cianchi, F.; Boddi, V.; Tonelli, F.; Cortesini, C.; Mazzei, T.; Genuardi, M.; Mini, E.
Cellular pharmacology of gemcitabine
2006-01-01 Mini, E.; Nobili, S.; Caciagli, B.; Landini, I.; Mazzei, T.
Pharmacological strategies for overcoming multidrug resistance
2006-01-01 Nobili, S.; Landini, B.; Giglioni, B.; Mini, E.
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules
2006-01-01 Tempestini, A.; Caciagli, B.; Morganti, M.; Witort, E.; Nobili, S.; Papucci, L.; Schiavone, N.; Donnini, M.; Landini, I.; Lapucci, A.; Perna, F.; Lulli, M.; Mazzei, T.; Sobrero, A.; Mini, E.; Capaccioli, S.
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer
2007-01-01 Cavalieri, D.; Dolara, P.; Mini, E.; Luceri, C.; Castagnini, C.; Toti, S.; Maciag, K.; De Filippo, C.; Nobili, S.; Morganti, M.; Napoli, C.; Tonini, G.; Baccini, M.; Biggeri, A.; Tonelli, F.; Valanzano, R.; Orlando, C.; Gelmini, S.; Cianchi, F.; Messerini, L.; Luzzatto, L.
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer
2008-01-01 Simi, L.; Pratesi, N.; Vignoli, M.; Sestini, R.; Cianchi, F.; Valanzano, R.; Nobili, S.; Mini, E.; Pazzagli, M.; Orlando, C.
Postoperative chemotherapy in resected gastric cancer: Results of a single center experience
2008-01-01 Bruno, L.; Nesi, G.; Nobili, S.; Veltri, M.; Girardi, L. R.; Boni, D.; Santomaggio, C.; Neri, B.; Boddi, V.; Bechi, P.; Mini, E.; Cortesini, C.
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy
2008-01-01 Nobili, S.; Checcacci, D.; Filippelli, F.; Del Buono, S.; Mazzocchi, V.; Mazzei, T.; Mini, E.
Pharmacogenetics: Implementing personalized medicine
2009-01-01 Mini, E.; Nobili, S.
Natural compounds for cancer treatment and prevention
2009-01-01 Nobili, S.; Lippi, D.; Witort, E.; Donnini, M.; Bausi, L.; Mini, E.; Capaccioli, S.
Exploring the biochemical mechanisms of cytotoxic gold compounds: A proteomic study
2010-01-01 Magherini, F.; Modesti, A.; Bini, L.; Puglia, M.; Landini, I.; Nobili, S.; Mini, E.; Cinellu, M. A.; Gabbiani, C.; Messori, L.
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, In combination with cisplatin In patients with advanced non-small-cell lung cancer
2010-01-01 Caffo, O.; Fallani, S.; Marangon, E.; Nobili, S.; Cassetta, M. I.; Murgia, V.; Sala, F.; Novelli, A.; Mini, E.; Zucchetti, M.; Galligioni, E.
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer
2010-01-01 Toffoli, G.; Cecchin, E.; Gasparini, G.; D'Andrea, M.; Azzarello, G.; Basso, U.; Mini, E.; Pessa, S.; De Mattia, E.; Lo Re, G.; Buonadonna, A.; Nobili, S.; De Paoli, P.; Innocenti, F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis? | 1997 | Mini, E.; Nobili, S.; Periti, P. | |
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance? | 2000 | Mini, E.; Nobili, S.; Periti, P. | |
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery | 2001 | Mini, E.; Grassi, F.; Cherubino, P.; Nobili, S.; Periti, P. | |
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma | 2001 | Martoni, A.; Mini, E.; Pinto, C.; Nobili, S.; Gentile, A. L.; Dentico, P.; Angelelli, B.; Scicolone, S.; Piana, E.; Mazzei, T. | |
Oxaliplatinum and 5-fluorouracil in protracted infusion in the treatment of advanced colorectal cancer | 2002 | Gentile, A. L.; Pinto, C.; Mini, E.; Angelelli, B.; Nobili, S.; Piana, E.; Mazzei, T.; Martoni, A. | |
Oxaliplatin plus Raltitrexed in the treatment of patients with advanced colorectal cancer: A phase II study | 2003 | Martoni, A.; Mini, E.; Pinto, C.; Gentile, A. L.; Nobili, S.; Dentico, P.; Marino, A.; Scicolone, S.; Angelelli, B.; Mazzei, T. | |
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: A pilot study | 2004 | Mazzanti, R.; Giallombardo, A. L.; Mini, E.; Nobili, S.; Neri, B.; Arena, U.; Pantaleo, P.; Fabbroni, V.; Ghilardi, M.; Gattai, R.; Bandettini, L. | |
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers | 2005 | Morganti, M.; Ciantelli, M.; Giglioni, B.; Putignano, A. L.; Nobili, S.; Papi, L.; Landini, I.; Napoli, C.; Valanzano, R.; Cianchi, F.; Boddi, V.; Tonelli, F.; Cortesini, C.; Mazzei, T.; Genuardi, M.; Mini, E. | |
Cellular pharmacology of gemcitabine | 2006 | Mini, E.; Nobili, S.; Caciagli, B.; Landini, I.; Mazzei, T. | |
Pharmacological strategies for overcoming multidrug resistance | 2006 | Nobili, S.; Landini, B.; Giglioni, B.; Mini, E. | |
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules | 2006 | Tempestini, A.; Caciagli, B.; Morganti, M.; Witort, E.; Nobili, S.; Papucci, L.; Schiavone, N.; Donnini, M.; Landini, I.; Lapucci, A.; Perna, F.; Lulli, M.; Mazzei, T.; Sobrero, A.; Mini, E.; Capaccioli, S. | |
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer | 2007 | Cavalieri, D.; Dolara, P.; Mini, E.; Luceri, C.; Castagnini, C.; Toti, S.; Maciag, K.; De Filippo, C.; Nobili, S.; Morganti, M.; Napoli, C.; Tonini, G.; Baccini, M.; Biggeri, A.; Tonelli, F.; Valanzano, R.; Orlando, C.; Gelmini, S.; Cianchi, F.; Messerini, L.; Luzzatto, L. | |
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer | 2008 | Simi, L.; Pratesi, N.; Vignoli, M.; Sestini, R.; Cianchi, F.; Valanzano, R.; Nobili, S.; Mini, E.; Pazzagli, M.; Orlando, C. | |
Postoperative chemotherapy in resected gastric cancer: Results of a single center experience | 2008 | Bruno, L.; Nesi, G.; Nobili, S.; Veltri, M.; Girardi, L. R.; Boni, D.; Santomaggio, C.; Neri, B.; Boddi, V.; Bechi, P.; Mini, E.; Cortesini, C. | |
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy | 2008 | Nobili, S.; Checcacci, D.; Filippelli, F.; Del Buono, S.; Mazzocchi, V.; Mazzei, T.; Mini, E. | |
Pharmacogenetics: Implementing personalized medicine | 2009 | Mini, E.; Nobili, S. | |
Natural compounds for cancer treatment and prevention | 2009 | Nobili, S.; Lippi, D.; Witort, E.; Donnini, M.; Bausi, L.; Mini, E.; Capaccioli, S. | |
Exploring the biochemical mechanisms of cytotoxic gold compounds: A proteomic study | 2010 | Magherini, F.; Modesti, A.; Bini, L.; Puglia, M.; Landini, I.; Nobili, S.; Mini, E.; Cinellu, M. A.; Gabbiani, C.; Messori, L. | |
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, In combination with cisplatin In patients with advanced non-small-cell lung cancer | 2010 | Caffo, O.; Fallani, S.; Marangon, E.; Nobili, S.; Cassetta, M. I.; Murgia, V.; Sala, F.; Novelli, A.; Mini, E.; Zucchetti, M.; Galligioni, E. | |
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer | 2010 | Toffoli, G.; Cecchin, E.; Gasparini, G.; D'Andrea, M.; Azzarello, G.; Basso, U.; Mini, E.; Pessa, S.; De Mattia, E.; Lo Re, G.; Buonadonna, A.; Nobili, S.; De Paoli, P.; Innocenti, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile